# Silver Sulphadiazine

## Siliverzine cream 1%， 20gm

##### 

| Title              | Content                                                                                                                                                                                                                                              |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | ESIL                                                                                                                                                                                                                                                 |
| Indications        | Adjunct for the prevention & treatment of wound sepsis in patients with 2nd & 3rd degree burns.                                                                                                                                                      |
| Dosing             | Burn treatment: Topical: Apply to a thickness of 1/16 inch QD -BID; reapply as needed to areas where the cream is removed by patient activity as the burned area should be covered with cream at all times. Continue use until healing has occurred. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                        |
| Contraindications  | Pregnancy， premature & newborn infants during 1st months of life.                                                                                                                                                                                   |
| Adverse Effects    | Burning， rash， itching， interstitial nephritis.                                                                                                                                                                                                   |
| Pregnancy          | Human data suggest risk in 3 rd trimester                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                         |

